In fact, key metabolic features of T2D, such as hyperinsulinemia, chronic low‐grade inflammation, and impaired glucose homeostasis, may modulate the functional effects of CDKN1B and TCF7L2 variants. Here, CDKN1B is linked to type 2 diabetes mellitus.